-
Alpa Laboratories Limited Q3FY23 Results
Alpa Laboratories Limited has reported a 15.4% increase in its net profit to Rs 21.7 crore for the quarter ended December 2022, as compared to Rs 18.8 crore in the corresponding quarter of the previous fiscal. The company's revenue from operations grew by 12.5% to Rs 121.3 crore during the quarter under review, as against Rs 107.9 crore in Q3FY22.
-
Alpa Laboratories Limited launches new product
Alpa Laboratories Limited has launched a new product, Alpa-Pro, a protein supplement powder. The product is available in two flavours, chocolate and vanilla, and is priced at Rs 1,499 for a 1 kg pack.
-
Alpa Laboratories Limited signs MoU with XYZ Company
Alpa Laboratories Limited has signed a Memorandum of Understanding (MoU) with XYZ Company to collaborate on the development and commercialization of new pharmaceutical products.
-
Alpa Laboratories Limited Announces New Partnership with Leading Healthcare Provider
Alpa Laboratories Limited (Alpa Labs), a leading provider of diagnostic services, has announced a new partnership with a renowned healthcare provider to expand its reach and offer a wider range of services to patients.
-
Alpa Labs Receives Accreditation for Excellence in Laboratory Services
Alpa Laboratories Limited (Alpa Labs) has been awarded accreditation by an internationally recognized organization for its high standards of laboratory services. This accreditation is a testament to Alpa Labs' commitment to quality and patient safety.
-
Alpa Labs Launches New State-of-the-Art Diagnostic Center
Alpa Laboratories Limited (Alpa Labs) has officially opened its new state-of-the-art diagnostic center. The new facility is equipped with the latest technology and offers a comprehensive range of diagnostic tests to meet the growing needs of patients.